The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...
Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo ...
Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback